Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: Report of the ACOSOG Z0040 trial

Journal of Clinical Oncology

Volumn 29, Issue 32, 2011, Pages 4313-4319

  Rusch, Valerie W ^a   Hawes, Debra ^b   Decker, Paul A ^c   Martin, Sue Ellen ^b   Abati, Andrea ^d   Landreneau, Rodney J ^e   Patterson, G Alexander ^f   Inculet, Richard I ^j   Jones, David R ^g   Malthaner, Richard A ^j   Cohen, Robbin G ^b   Ballman, Karla ^b   Putnam Jr , Joe B ^h   Cote, Richard J ⁱ  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BILOBECTOMY; BONE MARROW; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOLOGY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LOG RANK TEST; LUNG ADENOCARCINOMA; LUNG LAVAGE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; OCCULT METASTASIS; OVERALL SURVIVAL; PLEURA; PLEURA LAVAGE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RIB; WEDGE RESECTION;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 81155123176     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.35.2500     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
2. Goldstraw P, Crowley J, Chansky K, et al.: The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2:706-714, 2007 (Pubitemid 47357522)
3. Decker RH, Wilson LD: Postoperative radiation therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg 20:184-187, 2008
4. Wakelee H, Chhatwani L: Adjuvant chemotherapy for resected non-small cell lung cancer. Semin Thorac Cardiovasc Surg 20:198-203, 2008
5. Price KAR, Azzoli CG, Gaspar LE: Chemoradiation for unresectable stage III non-small cell lung cancer. Semin Thorac Cardiovasc Surg 20:204-209, 2008
6. Cote RJ, Rosen PP, Lesser ML, et al.: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749-1756, 1991
7. Braun S, Vogl FD, Naume B, et al.: A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793-802, 2005 (Pubitemid 41215488)
8. Lugo TG, Braun S, Cote RJ, et al.: Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol 21:2609-2615, 2003 (Pubitemid 46606345)
9. Pagliarulo V, Hawes D, Brands FH, et al.: Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol 24:2735-2742, 2006 (Pubitemid 46630570)
10. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al.: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339:223-228, 1998
11. International Union Against Cancer: TNM Classification of Malignant Tumours (ed 7). Oxford, United Kingdom, Wiley-Blackwell, 2009
12. Harichand-Herdt S, Ramalingam SS: Targeted therapy for the treatment of non-small cell lung cancer: Focus on inhibition of epidermal growth factor receptor. Semin Thorac Cardiovasc Surg 20: 217-223, 2008
13. Spjut HJ, Hendrix VJ, Ramirez GA, et al.: Carcinoma cells in pleural cavity washings. Cancer 11:1222-1225, 1958
14. Kjellberg SI, Dresler CM, Goldberg M: Pleural cytologies in lung cancer without pleural effusions. Ann Thorac Surg 64:941-944, 1997 (Pubitemid 27497362)
15. Pantel K, Izbicki JR, Angstwurm M, et al.: Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53:1027-1031, 1993 (Pubitemid 23087902)
16. Passlick B, Izbicki JR, Kubuschok B, et al.: Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 12:1827-1832, 1994 (Pubitemid 24349384)
17. Cote RJ, Beattie EJ, Chaiwun B, et al.: Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 222:415-425, 1995
18. Pantel K, Izbicki J, Passlick B, et al.: Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet 347:649-653, 1996 (Pubitemid 26076131)
19. Chen Z-L, Perez S, Holmes EC, et al.: Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small cell lung carcinoma. J Natl Cancer Inst 85:493-498, 1993 (Pubitemid 23084096)
20. Xi L, Coello MC, Litle VR, et al.: A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer Res 12:2484-2491, 2006
21. Maeda J, Inoue M, Okumura M, et al.: Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity. Lung Cancer 52:235-240, 2006
22. Saintigny P, Coulon S, Kambouchner M, et al.: Real-time RT-PCR detection of CK19, CK7, and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma. Int J Cancer 115:777-782, 2005 (Pubitemid 40776701)
23. Vollmer RT, Herndon JE II, D'Cunha J, et al.: Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: Anatomical pathology results from Cancer and Leukemia Group B trial 9761. Clin Cancer Res 9:5630-5635, 2003 (Pubitemid 37499484)
24. Rami-Porta R, Wittekind C, Goldstraw P: Complete resection in lung cancer surgery: Proposed definition. Lung Cancer 49:25-33, 2005 (Pubitemid 40798090)
25. Mountain CF, Dresler CM: Regional lymph node classification for lung cancer staging. Chest 111:1718-1723, 1997 (Pubitemid 27260108)
26. American Joint Committee on Cancer: AJCC Cancer Staging Manual (ed 6). New York, NY, Springer-Verlag, 2002
27. Cote RJ, Peterson HF, Chaiwun B, et al.: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer: International Breast Cancer Study Group. Lancet 354:896-900, 1999 (Pubitemid 29424019)
28. Shi S-R, Cote RJ, Chaiwun B, et al.: Standardization of immunohistochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections. Appl Immunohistochem 6:89-96, 1998 (Pubitemid 28311674)
29. American Joint Committee on Cancer: AJCC Cancer Staging Manual (ed 7). New York, NY, Springer, 2010
30. Lim E, Clough R, Goldstraw P, et al.: Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small cell lung cancer: An international individual patient data metaanalysis. J Thorac Cardiovasc Surg 139:1441-1446, 2010
31. Nicholson AG, Graham ANJ, Pezzella F, et al.: Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas? Lung Cancer 18:231-240, 1997 (Pubitemid 27522481)
32. Butts CA, Ding K, Seymour L, et al.: Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: Updated survival analysis of JBR-10. J Clin Oncol 28:29-34, 2010
33. Strauss GM, Herndon JE II, Maddaus MA, et al.: Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26:5043-5051, 2008
34. Bostick PJ, Chatterjee S, Chi DD, et al.: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632-2640, 1998 (Pubitemid 28363026)
35. Brock MV, Hooker CM, Ota-Machida E, et al.: DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 358:1118-1128, 2008 (Pubitemid 351398486)
36. Gupta GP, Massagué J: Cancer metastasis: Building a framework. Cell 127:679-695, 2006 (Pubitemid 44781029)
37. Pantel K, Brakenhoff RH, Brandt B: Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8:329-340, 2008 (Pubitemid 351596394)
38. Zheng S, Lin H, Liu JQ, et al.: Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 1162:154-161, 2007 (Pubitemid 47187403)
39. Cristofanilli M, Budd GT, Ellis MJ, et al.: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791, 2004 (Pubitemid 39095313)